FEV 1 Q as a race-neutral assessment of lung function in Nepal, Peru and Uganda
European Respiratory Journal · 2025
DOI: 10.1183/13993003.01830-2025 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Respiratory Journal, 2025. Verfasst von Ayadh Alayadhi und 14 weiteren Autor:innen. Beteiligte Einrichtung: UCL Respiratory, University College London, London, UK. Hauptthemen laut MEDLINE: Pulmonary Disease, Chronic Obstructive, Lung. Gefördert von: Medical Research Council, National Institute for Health and Care Research.
Abstract (Originalsprache)
Background
FEV 1 Q (Forced Expiratory Volume in 1 s Quotient) is a race-neutral expression of lung function. The validity and utility of FEV 1 Q across Global South populations has not been previously explored.
Methods
We conducted a post-hoc analysis of data from the Global Excellence in COPD Outcomes-1 (GECo1 and GECo2) studies in which a random age- and sex-stratified population of 10 709 people were recruited in Nepal, Peru and Uganda. The FEV 1 first percentile (used to derive FEV 1 Q) was estimated in those with COPD by site and sex. We examined associations between FEV 1 Q, risk factors and respiratory morbidity. We estimated the rate of decline in FEV 1 Q. We evaluated the discriminative accuracy of FEV 1 Q in diagnosing COPD.
Findings
The first percentile FEV 1 in those with COPD at 0·43 L in women and 0·52 L in men is similar to those previously used to calculate FEV 1 Q. Lower FEV 1 Q was associated with older age, lower socioeconomic status, shorter height, and greater smoking pack-years. We estimated that decline in FEV 1 Q with age was 0·65 (95%CI: 0·64; 0·67) units/10 years, more rapid in those continuing to smoke at 0·82 (95%CI: 0·77; 0·87) units/10 years. FEV 1 Q was lower in those with prior respiratory hospitalizations and impairment in daily activities due to respiratory disease, and associated with future hospitalization risk in the GECo2 study. Pre-bronchodilator FEV 1 Q had reasonable diagnostic accuracy for COPD (AUC 0·87(95%CI:0·85-0·88)), similar to pre-bronchodilator FEV 1 % predicted (AUC 0·88(95%CI:0·87-0·90)).
Interpretation
Our data support the validity and utility of FEV 1 Q as a race-neutral approach to lung function assessment in diverse settings, including the Global South where the burden of lung disease is greatest. Funding This study was funded by the Medical Research Council (grant MR/P008984/1) under a Global Alliance for Chronic Diseases call. JRH is funded by the NIHR (project reference 303125) using UK international development funding from the UK Government to support global health research. The views expressed in this publication are those of the authors and not necessarily those of the NIHR or the UK government.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- UCL Respiratory, University College London, London, UK.
- Prince Sultan Military College of Health Sciences, Dhahran, Saudi Arabia.
- These authors contributed equally to this work.
- Royal Free London NHS Foundation Trust, London, UK.
- Department of Chest Diseases and TB, Assiut University, Assiut, Egypt.
- TB Centre, London School of Hygiene and Tropical Medicine, London, UK.
ORCID-Profile: Arafa Aboelhassan, Patricia Alupo, Trishul Siddharthan, John R Hurst
Förderung
- Medical Research Council
- National Institute for Health and Care Research
Zitieren
APA
Alayadhi, A., Aboelhassan, A., Foster, N., Barber, J. A., Alupo, P., Chandyo, R. K., Flores-Flores, O., Kirenga, B., Mendes, R. G., Quaderi, S. A., Sharma, A. K., Siddharthan, T., Checkley, W., Hurst, J. R., & GECo Investigators (2025). FEV 1 Q as a race-neutral assessment of lung function in Nepal, Peru and Uganda. European Respiratory Journal. https://doi.org/10.1183/13993003.01830-2025
Vancouver
Alayadhi A, Aboelhassan A, Foster N, Barber JA, Alupo P, Chandyo RK, et al. FEV 1 Q as a race-neutral assessment of lung function in Nepal, Peru and Uganda. European Respiratory Journal. 2025. doi:10.1183/13993003.01830-2025
BibTeX
@article{Alayadhi2025,
author = {Alayadhi, Ayadh and Aboelhassan, Arafa and Foster, Nicola and Barber, Julie A and Alupo, Patricia and Chandyo, Ram K and Flores-Flores, Oscar and Kirenga, Bruce and Mendes, Renata G and Quaderi, Shumonta A and Sharma, Arun K and Siddharthan, Trishul and Checkley, William and Hurst, John R and GECo Investigators, GECo Investigators},
title = {FEV 1 Q as a race-neutral assessment of lung function in Nepal, Peru and Uganda},
journal = {European Respiratory Journal},
year = {2025},
doi = {10.1183/13993003.01830-2025}
}
EUVIMED